P2.01-45 Clinico-Molecular Characteristics and Prognostic Outcomes of TP53 Mutated Patients with Advanced Non-Small Cell Lung Cancer
Zizheng Song(Affiliated Hospital of Hebei University), Aimin Zang(Affiliated Hospital of Hebei University), K. Wang(Affiliated Hospital of Hebei University), Haiying Cheng(Karlsruhe Institute of Technology), Xiao-Bin Wang(Affiliated Hospital of Hebei University), H. Wang(Zhejiang University), Ling Hu(Shihezi University), Bin Yin(Chinese Academy of Medical Sciences & Peking Union Medical College), F. Lou, Youchao Jia(Affiliated Hospital of Hebei University), Quanli Han(Xijing Hospital), Jin Song(Affiliated Hospital of Hebei University), Shougen Cao(Qingdao University), Ting Jiao(Shanghai Jiao Tong University), Yaoyang Huo(Affiliated Hospital of Hebei University), Gang Ren(Capital Institute of Pediatrics)
Cited by 0
Related Papers
Update 2020: Management of Non-Small Cell Lung Cancer
|Lung|2020|649
Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable <i>MET</i> Gene Mutations
|Journal of Clinical Oncology|2015|343
Methylene Blue-Mediated Photodynamic Therapy Induces Macrophage Apoptosis via ROS and Reduces Bone Resorption in Periodontitis
|Oxidative Medicine and Cellular Longevity|2019|71
Epigenetic silencing of DACH1 induces loss of transforming growth factor-<i>β</i>1 antiproliferative response in human hepatocellular carcinoma
|Hepatology|2013|67
The papain-like cysteine protease CEP1 is involved in programmed cell death and secondary wall thickening during xylem development in Arabidopsis
|Journal of Experimental Botany|2018|55